If you want to ask questions about the "following", then I suggest that you make sure that there is something that is following.
You conduct the appropriate experiment repeatedly and calculate the proportion of times that the specified event occurs compared with the total number of experimental trials.You conduct the appropriate experiment repeatedly and calculate the proportion of times that the specified event occurs compared with the total number of experimental trials.You conduct the appropriate experiment repeatedly and calculate the proportion of times that the specified event occurs compared with the total number of experimental trials.You conduct the appropriate experiment repeatedly and calculate the proportion of times that the specified event occurs compared with the total number of experimental trials.
If we are discussing clinical trials of a pharmaceutical or medical device then the greater the number of trials:the greater the likelihood of exposing risks and risk factors, side effects, etcthe greater the likelihood of finding possible secondary benefitsthe greater the statistical confidence that can be placed on numerical resultsthe more types of populations that are likely to be exposed to the trial substance or device for testing
No. The more trials the better. You can only estimate the probability of an outcome based on the data from experimentation. But if you find that the percentage in 90 trials is practically identical to the percentage in 30 trials, that is an indication that the percentage will hold true for even larger numbers of trials.
Number of trials is how many times you test your hypothesis. When you are doing trials the end result may come out differently every time.
There are no clinical trials for Dandy-Walker syndrome
Tom Brody has written: 'Clinical trials' -- subject(s): Research Design, Clinical Trials Data Monitoring Committees, Drug Approval, Clinical Trials as Topic, Clinical trials, Drug approval
Clinical trials are experiments to find out how effective a drug is, and if there are any side effects. The stakeholders in clinical trials are the patients, doctors, drug companies, drug manufacturers, and pharmacists.
You can find out about clinical trials at the National Institutes of Health clinical trials website (http://clinicaltrials.gov/). This includes all clinical trial currently in progress in the US and you search by conditions, interventions, location and more.
Because they are :)
Avicenna
Annpey Pong has written: 'Handbook of adaptive designs in pharmaceutical and clinical development' -- subject(s): Research Design, Clinical trials, Drugs, Handbooks, manuals, Clinical Trials as Topic, Statistics as Topic, Methodology, Research, Methods 'Handbook of adaptive designs in pharmaceutical and clinical development' -- subject(s): Research Design, Clinical trials, Drugs, Handbooks, manuals, Clinical Trials as Topic, Statistics as Topic, Methodology, Research, Methods 'Handbook of adaptive designs in pharmaceutical and clinical development' -- subject(s): Research Design, Clinical trials, Drugs, Handbooks, manuals, Clinical Trials as Topic, Statistics as Topic, Methodology, Research, Methods
yes
Clinical trials are controlled and paid experiments using humans as subjects. The clinical trials may consists of taking medicines or administration of it to an informed individual or group of informed individuals. The results from these trials are used for the improvement of certain treatment modalities or how to control a specific illness.
One can find clinical research trials either in a local clinic. Alternatively, one can go online to find such trials in the following websites: ClinicalTrials or ClinicalResearchTrials.
There is very little cannibalism in clinical trials
As of 2004, the National Cancer Institute is sponsoring 10 clinical trials of treatments for ocular melanoma in adults and 5 trials for treatments of retinoblastoma in children. These trials allow researchers to investigate new types of.